Jingtao Zhong

No. 324 Jingwu Road
Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas.

Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas.

Journal: Frontiers in immunology

Published: August 06, 2025

Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas.

Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas.

Journal: Frontiers in immunology

Published: June 08, 2025

Efficacy and liver function preservation with donafenib combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An ALBI grade analysis.

Efficacy and liver function preservation with donafenib combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An ALBI grade analysis.

Journal: Frontiers in oncology

Published: April 15, 2025

Navigating the complexities: challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma.

Navigating the complexities: challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma.

Journal: Clinical and experimental medicine

Published: January 18, 2025

PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway.

PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway.

Journal: Molecular and cellular biochemistry

Published: November 11, 2024

Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.

Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.

Journal: BMC cancer

Published: October 25, 2024

Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years.

Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years.

Journal: BMC gastroenterology

Published: June 27, 2024

Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU.

Comparison of the effects of perioperative fentanyl and morphine use on the short-term prognosis of patients with cardiac surgery in the ICU.

Journal: Frontiers in pharmacology

Published: June 24, 2024

Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.

Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.

Journal: Frontiers in oncology

Published: December 14, 2023

Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma: A prospective clinical study.

Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma: A prospective clinical study.

Journal: Journal of cancer research and therapeutics

Published: November 01, 2023

Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study.

Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study.

Journal: iLIVER

Published: November 01, 2023

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

Journal: BMC cancer

Published: December 10, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026